With obesity and type 2 diabetes on the rise, semaglutide and tirzepatide have emerged as two promising treatments. Both medications mimic the hormone GLP-1, which regulates insulin production, slows digestion, and creates a sense of fullness to support weight loss. Tirzepatide also targets GIP receptors, offering a dual-action mechanism that may enhance its effects. Semaglutide is available as a daily oral tablet or a weekly injection, while tirzepatide is limited to weekly injections. Both medications can cause side effects like nausea, diarrhea, and fatigue, which are often dose-dependent and decrease over time. Cost is a factor, with semaglutide averaging $23,000 for a 68-week course, while tirzepatide costs around $17,500 for 72 weeks. Clinical studies suggest tirzepatide may lead to slightly more significant weight loss, possibly due to its dual mechanism. However, semaglutide remains effective and offers the convenience of a tablet option. Choosing between the two depends on individual health needs, tolerance to side effects, and insurance coverage. Consulting a healthcare provider can help determine which medication aligns best with your treatment goals and lifestyle.
source: https://direct-meds.com/semaglutide-vs-tirzepatide-whats-the-difference/
Comments
Download this infographic.